section name header

Interacting Drugs

OBJECT DRUGS

Kinase Inhibitors:

PRECIPITANT DRUGS

Enzyme Inhibitors:


Comment:

Although data are limited, assume that all CYP3A4 inhibitors may increase the plasma levels of kinase inhibitors. Toxicity including skin rashes, anemia, hemorrhage, and gastrointestinal symptoms could result.


Class 3: Assess Risk & Take Action if Necessary